Alignment Healthcare Inc (NASDAQ: ALHC): Think Like A Lender, Not An Investor

Alignment Healthcare Inc (NASDAQ:ALHC) currently has a daily average trading volume of 3.36M but it saw 2949276 shares traded in last market. With a market cap of 2.98B USD, the company’s current market price of $15.08 came falling about -2.33 while comparing to the previous closing price of $15.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $21.06 and as low as $7.05. In the recent trading on the day, stock has struck highest price mark of $14.99 while lowest mark touched by it was $15.73.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Stephens which upgraded the stock as “Overweight” in its note to investors issued on December 03, 2024, recommending a price target of between $13 and $17 for it. BofA Securities also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $7.75 and $11.

Over the week, ALHC’s stock price is moving 1.96% up while it is 7.33% when we observe its performance for the past one month. Year-to-date it is 34.04% up and over the past year, the stock is showing an upside performance of 80.17%.

The company is expected to be releasing its next quarterly report on 2025-Apr-30, for which analysts forecasted an EPS of -0.01 while estimate for next year EPS is 0.01. In next quarter, company is expected to be making quarterly sales of $956.15M as analysts are expecting the sales for current fiscal year at $3.8B and seeing the company making $4.81B in sales next year. Moreover, analysts are in estimates of $960.25M for current-quarter revenue.

Currently, Alignment Healthcare Inc’s total number of outstanding shares is 197.67M with 6.16% of that held by the insiders while 92.75% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.71% and return on equity (ROE) at -75.82%. Stock’s beta reads 1.22. Stock has a price to book (P/B) ratio of 27.57 while price to sale or P/S ratio amounts to 0.99. Its return on asset (ROA) is -11.86% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.